Order Article Reprints

Ikeda S, Sugihara T, Kihara T, Matsuki Y, Nagahara T, Takata T, Kitao S, Okura T, Yamamoto K, Isomoto H. Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up. Diagnostics. 2021; 11(12):2316. https://doi.org/10.3390/diagnostics11122316

Ikeda, Suguru, Takaaki Sugihara, Takuya Kihara, Yukako Matsuki, Takakazu Nagahara, Tomoaki Takata, Sonoko Kitao, Tsuyoshi Okura, Kazuhiro Yamamoto, and Hajime Isomoto. 2021. "Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up" Diagnostics 11, no. 12: 2316. https://doi.org/10.3390/diagnostics11122316

Ikeda, S., Sugihara, T., Kihara, T., Matsuki, Y., Nagahara, T., Takata, T., Kitao, S., Okura, T., Yamamoto, K., & Isomoto, H. (2021). Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up. Diagnostics, 11(12), 2316. https://doi.org/10.3390/diagnostics11122316